Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis by Fountoulakis, Konstantinos N et al.
MEETING ABSTRACT Open Access
Aripiprazole monotherapy in the treatment
of bipolar disorder: a meta-analysis
Konstantinos N Fountoulakis
1*, Eduard Vieta
2, Frank Schmidt
3
From 1
st International Congress on Neurobiology and Clinical Psychopharmacology and European
Psychiatric Association Conference on Treatment Guidance
Thessaloniki, Greece. 19-22 November 2009
Background
The current article is a systematic registration and
meta-analysis of the available clinical trials concerning
the usefulness of aripiprazole in the treatment of bipolar
disorder.
Materials and methods
A systematic MEDLINE and repositories search con-
cerning treatment guidelines and clinical trials for aripi-
prazole in bipolar disorder.
Results
The pooled effect size for acute mania was equal to
0.34. The NNT was 6 for aripiprazole vs placebo con-
cerning response at week 3 and equal to 14 concerning
remission. The average day response started was day 3.
The switch rates were peculiarly in favour of haloperidol
and against lithium. The suicide rates were negligible
for all groups. The meta-analysis for acute bipolar
depression suggests a significant difference at week 8
with an effect size 0.17. The maintenance data suggest
that the median survival time for the aripiprazole group
was not evaluable, while the median survival time for
placebo was 118-203 days depending on the clinical
subpopulation.
Conclusions
The data analysed for the current study support the use-
fulness of aripiprazole during all phases of bipolar ill-
ness, inpite of the rather weak effect on depression and
that the efficacy during the maintenance period is pro-
ven only against new manic episodes and in patients
with an index manic episode who responded to aripipra-
zole during the acute phase.
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